Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cerevel Therapeutics Holdings, Inc. (CERE)  
$42.55 0.04 (0.09%) as of 4:30 Fri 5/3


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 156,320,000
Market Cap: 6.65(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $20.26 - $43.27
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Cerevel Therapeutics Holdings is a clinical-stage biopharmaceutical company. Co.'s programs: Emraclidine is a positive allosteric modulator (PAM), that selectively targets the muscarinic acetylcholine 4 receptor subtype; Darigabat, which is a PAM that selectively targets the alpha-2/3/5 subunits of the GABAA receptor; Tavapadon, which is a selective dopamine D1/D5 receptor partial agonist that it is developing for the treatment of early- and late-stage Parkinson's disease; and CVL-871, which is a selective dopamine D1/D5 receptor partial agonist specifically designed to achieve a level of partial agonism.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 17,422,701 18,847,701
Total Buy Value $0 $0 $397,510,553 $447,385,553
Total People Bought 0 0 6 6
Total Buy Transactions 0 0 6 7
Total Shares Sold 154,667 359,132 611,027 1,200,893
Total Sell Value $6,418,967 $14,072,755 $21,003,717 $39,590,443
Total People Sold 2 8 8 10
Total Sell Transactions 5 21 27 48
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 181
  Page 6 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Renger John Chief Scientific Officer   •       –      –    2022-03-16 4 OE $3.50 $87,500 D/D 25,000 26,980     -
   Renger John Chief Scientific Officer   •       –      –    2022-03-09 4 AS $32.50 $1,000,000 D/D (30,000) 1,980 -21%     
   Renger John Chief Scientific Officer   •       –      –    2022-03-09 4 OE $3.50 $105,000 D/D 30,000 31,980     -
   Renger John Chief Scientific Officer   •       –      –    2022-03-02 4 AS $30.00 $750,000 D/D (25,000) 1,980 -11%     
   Renger John Chief Scientific Officer   •       –      –    2022-03-02 4 OE $3.50 $87,500 D/D 25,000 26,980     -
   Renger John Chief Scientific Officer   •       –      –    2022-02-09 4 AS $30.00 $750,000 D/D (25,000) 1,980 -17%     
   Renger John Chief Scientific Officer   •       –      –    2022-02-09 4 OE $3.50 $87,500 D/D 25,000 26,980     -
   Riedel Norbert G Director   –       •      –    2022-01-04 4 OE $0.00 $0 D/D 14,270 42,810     -
   Renger John Chief Scientific Officer   •       –      –    2021-12-27 4 AS $35.00 $144,445 D/D (4,127) 1,980 -17%     
   Renger John Chief Scientific Officer   •       –      –    2021-12-27 4 OE $3.50 $14,445 D/D 4,127 6,107     -
   Renger John Chief Scientific Officer   •       –      –    2021-12-23 4 AS $35.00 $205,582 D/D (5,873) 1,980 -8%     
   Renger John Chief Scientific Officer   •       –      –    2021-12-23 4 OE $3.50 $20,556 D/D 5,873 7,853     -
   Renger John Chief Scientific Officer   •       –      –    2021-12-21 4 AS $32.50 $237,250 D/D (7,300) 1,980 -8%     
   Renger John Chief Scientific Officer   •       –      –    2021-12-21 4 OE $3.50 $25,550 D/D 7,300 9,280     -
   Renger John Chief Scientific Officer   •       –      –    2021-12-17 4 AS $32.50 $231,465 D/D (7,122) 1,980 -7%     
   Renger John Chief Scientific Officer   •       –      –    2021-12-17 4 OE $3.50 $24,927 D/D 7,122 9,102     -
   Renger John Chief Scientific Officer   •       –      –    2021-12-16 4 AS $32.50 $181,285 D/D (5,578) 1,980 4%     
   Renger John Chief Scientific Officer   •       –      –    2021-12-16 4 OE $3.50 $19,523 D/D 5,578 7,558     -
   Renger John Chief Scientific Officer   •       –      –    2021-12-15 4 AS $30.02 $750,448 D/D (25,000) 1,980 -1%     
   Renger John Chief Scientific Officer   •       –      –    2021-12-15 4 OE $3.50 $87,500 D/D 25,000 26,980     -
   Renger John Chief Scientific Officer   •       –      –    2021-11-10 4 AS $38.59 $2,192,187 D/D (55,000) 0 -12%     
   Renger John Chief Scientific Officer   •       –      –    2021-11-10 4 OE $3.50 $192,500 D/D 55,000 55,000     -
   Dekkers Marijn E Director   –       •      –    2021-09-24 4 OE $0.00 $0 D/D 14,270 42,810     -
   Pf Equity Holdings 1 B.v. 10% Owner   –       –       •   2021-09-10 3 IO $0.00 $0 D/D 0 27,349,211 -31%     
   Edelman Joseph Director   –       •      –    2021-08-26 4 B $30.23 $2,057,061 I/I 68,047 5,086,727 2.1 4%     
  181 Records found
  1  2  3  4  5  6  7  8   
  Page 6 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us